Evidence suggests that the MEK5/ERK5 axis plays an essential role in BC tumorigenesis; for example, ERK5 activation promotes the growth and maintenance of BC cells via regulation of the extracellular matrix [4]. This evidence concerns the gene MAP2K5 and breast cancer.